• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

AMA: Halt Implementation of ICD-10

On January 17, 2012, AMA CEO James L. Madara, MD, wrote to House Speaker John A. Boehner, urging the halt of the required implementation of ICD-10 under the Health Insurance Portability and Accountability Act (HIPAA). Madara outlines the reasons why ICD-10 would place unnecessary burden on physicians with no added patient benefit.

Dr. Madara showed that a five-fold increase in current codes and the need for education, software, coder training, and testing with payers would significantly increase the cost to physicians as a result of code compliance.

“As HIPAA covered entities, physicians are responsible for complying with this ICD-10 mandate, and therefore must bear the entire cost of such a transition, without any financial aid from the government,” Madara noted. “Depending on the size of a medical practice, the total cost of implementing ICD-10 ranges from $83,290 to more than $2.7 million.”

In addition to rising costs, physicians are currently spending time and resources transitioning to electronic health records (EHRs) in their practices, but the implementation of ICD-10 will disrupt current health IT efforts. As a result, Dr. Madara urged Speaker Boehner to “re-evaluate the penalty program timelines associated with the e-prescribing, meaningful use, and PQRS programs.”

Resynchronizing federal health IT programs will help physicians persevere in their transition to various health IT and reporting requirements, as well as help their ability to participate in practice redesign and reforms visualized under the Affordable Care Act.

Dr. Madara argues that stopping ICD-10 will help physicians:

  • Continue the adoption of EHRs;
  • Participate in quality and health IT programs;
  • Reduce costly burdens. 

To download the full letter from James L. Madara, click here.

image description image description


				

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to Open AAA Repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
  • Self-Expanding and Balloon-Expandable Stent Systems Perform Well in Study of Real-World Peripheral Artery Disease Patients
    Fri, 05/11/12 - 11:06am
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications